Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 69, Issue 11, 2010, Pages 1951-1957

  Krause, Lijana ^a   Becker, Mike O ^a   Brueckner, Claudia S ^a   Bellinghausen, Christina Julia ^a   Becker, Corinna ^a   Schneider, Udo ^a   Haeupl, Thomas ^a   Hanke, Katharina ^a   Hensel Wiegel, Karin ^a   Ebert, Heidrun ^a   Ziemer, Sabine ^a   Ladner, Ulf Müller ^b   Pirlich, Matthias ^a   Burmester, Gerd R ^a   Riemekasten, Gabriela ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL METABOLIC RATE; BODY MASS; CALORIC INTAKE; DISEASE ACTIVITY; DISEASE SEVERITY; EXTRACELLULAR SPACE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SYSTEMIC SCLEROSIS; ADOLESCENT; BODY COMPOSITION; EPIDEMIOLOGY; GERMANY; IMPEDANCE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; ELECTRIC IMPEDANCE; EPIDEMIOLOGIC METHODS; GERMANY; HUMANS; MALNUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; PROGNOSIS; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 78149480634     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.123273     Document Type: Article

References (37)

1. Schmidt K, Martinez-Gamboa L, Meier S, et al. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients. Arthritis Res Ther 2009;11:R111.
2. Valentini G, Bencivelli W, Bombardieri S, et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003;62:901-3.
3. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
4. D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428-40.
5. Saar P, Schmeiser T, Tarner IH, et al. [Gastrointestinal involvement in systemic sclerosis. An underestimated complication]. Hautarzt 2007;58:844-50.
6. de Oliveira NC, dos Santos Sabbag LM, Ueno LM, et al. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement. Scand J Rheumatol 2007;36:458-61.
7. Baron M, Hudson M, Steele R. Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 2009;36:2737-43.
8. Akesson A, Wollheim FA. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 1989;28:281-6.
9. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430-53.
10. Kyle UG, Bosaeus I, De Lorenzo AD, et al.; Composition of the ESPEN Working Group. Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 2004;23:1226-43.
11. Lundberg AC, Akesson A, Akesson B. Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis 1992;51:1143-8.
12. Souza RB, Borges CT, Takayama L, et al. Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 2006;35:384-7.
13. Cohen S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980;79:155-66.
14. Akesson A, Gustafson T, Wollheim F, et al. Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis. Scand J Rheumatol 1987;16:291-9.
15. Giles JT, Bartlett SJ, Andersen RE, et al. Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum 2008;59:1407-15.
16. Roubenoff R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Res Ther 2009;11:108.
17. Jaffrin MY. Body composition determination by bioimpedance: an update. Curr Opin Clin Nutr Metab Care 2009;12:482-6.
18. Ellis KJ. Human body composition: in vivo methods. Physiol Rev 2000;80:649-80.
19. Norman K, Pichard C, Lochs H, et al. Prognostic impact of disease-related malnutrition. Clin Nutr 2008;27:5-15.
20. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
21. Walker UA, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754-63.
22. Hunzelmann N, Genth E, Krieg T, et al.; Registry of the German Network for Systemic Scleroderma. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 2008;47:1185-92.
23. Furst DE, Clements PJ, Steen VD, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in SSc. J Rheumatol 1998;25:184-8.
24. Hanke K, Dähnrich C, Brückner CS, et al. Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort. Arthritis Res Ther 2009;11:R28.
25. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.
26. Pirlich M, Biering H, Gerl H, et al. Loss of body cell mass in Cushing's syndrome: effect of treatment. J Clin Endocrinol Metab 2002;87:1078-84.
27. Bellizzi V, Scalfi L, Terracciano V, et al. Early changes in bioelectrical estimates of body composition in chronic kidney disease. J Am Soc Nephrol 2006;17:1481-7.
28. Elkan AC, Engvall IL, Cederholm T, et al. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 2009;48:315-22.
29. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, et al. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol 2009;28:439-44.
30. Roubenoff R, Roubenoff RA, Ward LM, et al. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 1992;19:1505-10.
31. Allanore Y, Wahbi K, Borderie D, et al. N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment? Ann Rheum Dis 2009;68:1885-9.
32. Marie I, Ducrotté P, Denis P, et al. Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford) 2009;48:1314-19.
33. Walsmith J, Abad L, Kehayias J, et al. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 2004;31:23-9.
34. Summers GD, Deighton CM, Rennie MJ, et al. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford) 2008;47:1124-31.
35. Garrel D, Patenaude J, Nedelec B, et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med 2003;31:2444-9.
36. Catto-Smith AG, Jimenez S. Morbidity and mortality after percutaneous endoscopic gastrostomy in children with neurological disability. J Gastroenterol Hepatol 2006;21:734-8.
37. Pupelis G, Selga G, Austrums E, et al. Jejunal feeding, even when instituted late, improves outcomes in patients with severe pancreatitis and peritonitis. Nutrition 2001;17:91-4.